Research Article
Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
Table 2
Univariate and multivariate analysis of overall survival in LUAD patients.
| Characteristics | Total () | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Gender | 526 | | | | | Female | 280 | Reference | | | | Male | 246 | 1.070 (0.803-1.426) | 0.642 | | | Age | 516 | | | | | < =65 | 255 | Reference | | | | >65 | 261 | 1.223 (0.916-1.635) | 0.172 | | | Pathologic stage | 518 | | | | | Stage I and stage II | 411 | Reference | | | | Stage III and stage IV | 107 | 2.664 (1.960-3.621) | <0.001 | 2.490 (1.829-3.391) | <0.001 | GPD1L | 526 | | | | | Low | 263 | Reference | | | | High | 263 | 0.492 (0.365-0.662) | <0.001 | 0.521 (0.386-0.705) | <0.001 |
|
|